-15.3%
DXCM vs SBAC
-6.5%
-8.7%
-61.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +2.4% | +1.5% | +0.9% | +2.2% |
| 7D | +4.9% | +0.6% | +4.3% | +4.9% |
| 30D | -0.2% | +5.5% | -5.6% | -0.6% |
| 3M | -8.9% | +3.1% | -12.0% | -9.1% |
| 6M | +42.3% | -7.0% | +49.3% | +42.8% |
| YTD | +25.6% | +0.5% | +25.1% | +25.6% |
| 1Y | +39.5% | +0.2% | +39.3% | +39.6% |
| 3Y | -15.3% | -7.4% | -7.9% | -11.3% |
| All | -15.3% | -6.5% | -8.7% | -11.3% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling